40.54 USD
↘ 0.05 (0.12%)AT CLOSE (11:59 AM EDT)
Indivior Pharmaceuticals, Inc. Common Stock
INDVNASDAQ • USD
40.67
↗ 0.13 (0.32%)
POST MARKET (AS OF 07:54 PM EDT)
Post Market
AS OF 07:54 PM EDT
40.67
↗ 0.13 (0.32%)
Market: CLOSED
INDV is currently priced at $40.55. The stock presents a mixed profile: our models indicate a Buy for technical indicators, while underlying fundamentals flash a Sell. Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. INDV is fairly valued relative to its sector peers based on current multiples.
Technical & fundamental data as of Jul 17, 2026.
Open?$40.28
High?$41.01
Low?$39.99
Prev. Close?$40.59
Volume?984.7K
Avg. Volume?1.8M
VWAP?$40.65
Rel. Volume?0.55x
Bid / Ask
Bid?$35.23 × 100
Ask?$46.44 × 100
Spread?$11.21
Midpoint?$40.83
Valuation & Ratios
Market Cap?4.8B
Shares Out?121.9M
Float?113.4M
Float %?93.0%
P/E Ratio?19.12
P/B Ratio?-33.32
EPS?$2.12
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).
Employees
838
Market Cap
4.8B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2014-12-24
Address
10710 MIDLOTHIAN TURNPIKE
NORTH CHESTERFIELD, VA 23235
Phone: 804-379-1090
NORTH CHESTERFIELD, VA 23235
Phone: 804-379-1090
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?88
Momentum?73
Short Sent.?45
Piotroski F-Score?0/9Weak
Altman Z-Score?3.70Safe
Confidence?49%Low
Short InterestElevated
Short % of Float?9.50%Elevated
Short Interest?10.8M
Days to Cover?4.7
Free Float113.4M
Avg Daily Volume2.3M
Settlement Date2026-06-30
Financial Health
Current Ratio?0.86Weak
Quick Ratio?0.66Weak
Cash Ratio?0.22Low
Debt/Equity?-3.38Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score73/100
P/E?19.1FAIR▾
Peers100
S&P68
P/B?-33.32CHEAP▾
S&P97
P/S?3.72FAIR▾
Peers100
S&P41
P/FCF?N/A▾
EV/EBITDA?15.0FAIR▾
Peers100
S&P50
EV/Sales?3.96FAIR▾
Peers100
S&P47
Returns & Efficiency
ROE?-174.3%WEAK▾
S&P3
ROA?21.0%STRONG▾
Peers50
S&P97
Cash Flow & Enterprise
FCF?$-193000000
Enterprise Value?$5.1B
Fundamentals ratios updated end of day